Fentanyl in palliative care: From pharmacology to clinical use

被引:3
|
作者
Guirimand, Frederic [1 ]
机构
[1] Maison Med Jeanne Garnier, 106,Ave Emile Zola, F-75015 Paris, France
来源
MEDECINE PALLIATIVE | 2011年 / 10卷 / 06期
关键词
Fentanyl; Palliative care; Pharmacology; Breakthrough pain; Pain;
D O I
10.1016/j.medpal.2010.11.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Fentanyl is a synthetic opioid analgesic with lipophilic, short-acting properties. In cancer-related pain, transdermic fentanyl is widely used for baseline pain. Injectable form was reserved to anaesthesia but is now available by intravenous or subcutaneous route in cases of refractory pain with failure or unmanageable adverse events after morphine or oxycodone. Buccal or intranasal transmucosal forms have shown efficacy for the management of breakthrough pain; titration period is necessary to determine the dose that produced satisfactory pain relief, which is not related to the baseline dose. This article reviews the pharmacokinetics, pharmacodynamics and clinical efficacy of these various forms of fentanyl. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码:296 / 305
页数:10
相关论文
共 50 条
  • [1] Clinical practice of palliative care superimpose on basic pharmacology
    Matoba, Motohiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 44P - 44P
  • [2] Use of transdermal fentanyl in neonates in palliative care, about three cases
    Vlieghe, Vinciane
    Avino, Daniela
    Fonteyne, Christine
    Johansson, Anne-Britt
    MEDECINE PALLIATIVE, 2022, 21 (04): : 210 - 215
  • [3] Pharmacology of cough in palliative care
    Morice, Alyn H.
    Shanks, Gabriella
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2017, 11 (03) : 147 - 151
  • [4] TRANSDERMAL FENTANYL - CLINICAL-PHARMACOLOGY
    LEHMANN, KA
    ZECH, D
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (03) : S8 - S16
  • [5] Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit
    Botterman, J.
    Criel, N.
    PALLIATIVE MEDICINE, 2011, 25 (02) : 111 - 116
  • [6] Deprescribing in palliative care; is there a role for clinical pharmacology to support decision making?
    Wightman, F.
    Rowland, T.
    Hanchanale, S.
    Dickman, A.
    Walker, L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S85 - S86
  • [7] Intranasal Fentanyl in the Palliative Care of Newborns and Infants
    Harlos, Michael S.
    Stenekes, Simone
    Lambert, David
    Hohl, Chris
    Chochinov, Harvey Max
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 46 (02) : 265 - 274
  • [8] NEUROLEPTANALGESIA - PHARMACOLOGY AND CLINICAL EXPERIENCES WITH DROPERIDOL AND FENTANYL
    FERRARI, HA
    STEPHEN, CR
    SOUTHERN MEDICAL JOURNAL, 1966, 59 (07) : 815 - &
  • [9] Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care
    McNamara, P
    PALLIATIVE MEDICINE, 2002, 16 (05) : 425 - 434
  • [10] Transdermal fentanyl in palliative care - A series of five cases
    O'Siorain, L
    CLINICAL DRUG INVESTIGATION, 1998, 16 (01) : 88 - 91